The requirements for patenting life science inventions under the European Patent Convention (EPC) are different compared to other jurisdictions. Recent US Supreme court exclusions do not apply in Europe and protection can still be sought for diagnostic methods - such as genotyping - involving “natural phenomena”. To file a successful application in Europe, it is important to be aware of the general requirements that apply under the EPC with regard to priority entitlements, claim dependencies, and added matter. Panellists will discuss the differences between the US and the European patent systems and will provide insights into the granting policy at the European Patent Office. The session will finish with a claim drafting exercise in the field of diagnostics, antibodies, cells obtained by CRISPR/Cas such as CAR T-cells and personalized medicine.